JXR (01951) repurchased 2.2035 million shares on October 29 for HK$4.9519 million.
JXR (01951) announced that on October 29, 2026, it repurchased 2.2035 million shares for HK$4.9519 million.
JXR (01951) announced that on October 29, 2026, it repurchased 2.2035 million shares for HK$4.9519 million.
Related Articles
JUNSHI BIO (01877): First patient dosed in Phase III clinical trial of JS207 combined with JS007 for first-line treatment of advanced hepatocellular carcinoma
CHINA VANKE (02202) Announces First Three Quarters Results, Revenue RMB104.999 Billion, Delivered 34,000 Homes on Schedule and with Quality
ZCZL Industrial Technology Group (00564) reported a net profit attributable to shareholders of RMB2.465 billion for the first three quarters, down 32.37% year on year.
JUNSHI BIO (01877): First patient dosed in Phase III clinical trial of JS207 combined with JS007 for first-line treatment of advanced hepatocellular carcinoma
CHINA VANKE (02202) Announces First Three Quarters Results, Revenue RMB104.999 Billion, Delivered 34,000 Homes on Schedule and with Quality
ZCZL Industrial Technology Group (00564) reported a net profit attributable to shareholders of RMB2.465 billion for the first three quarters, down 32.37% year on year.
